Home
Seagen

Seagen Market Share Analysis for June 2026

discover the commonalities and differences between biologics vs. biosimilars — especially when it comes to cost.

Health > Biotechnology and Pharmaceuticals

Domainseagen.com

Year Founded1998

Employees1001 - 5000

Annual Revenue> $1B

Seagen

Seagen (including company regionals)

seagen.com

See more website traffic and engagement information

Seagen Revenue up to June 2026 is > 1B

revenue generated by Seagen top domains

Seagen top domains revenue over 3 years

Revenue for Seagen top domains

seagen.com> 1B

See more with Sales Intelligence

Total visits to Seagen's top domains

Understand Seagen market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Seagen's top domains

Analyze Seagen engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Seagen's top domains

See how Seagen keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Seagen top competitors by domain

Top similar sites in June 2026, ranked by their affinity

seattlegenetics.comCompany NameSeattle GeneticsEmployees1001 - 5000HQUnited StatesAnnual revenue--Total visits--Health > Biotechnology and Pharmaceuticals

Top technologies used by Seagen

These are the website technologies, by industry, used by Seagen top domains

Content Management System (3)

Web Dot Com

Advertising (2)

PubMatic

Audio Video Media (2)

Vimeo

Marketing (2)

Google Marketing Platform

More Technologies

7

See all

News & Signals from Seagen

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsPatton leaves seagen.com as director of corporate affairs.Patton joins Golin from drugmaker Seagen, where she served as director of corporate affairs.

NewsAlley leaves seagen.com as executive director, translational sciences.Dr. Alley joins MBrace Therapeutics from Seagen where he served as executive director, translational sciences.

Newsseagen.com invested into assets: manufacturing site in the amount of $350M on Apr 1st '22.Seagen revealed its plan to build the $350 million manufacturing site in April of 2022 to gain "greater control and flexibility over the production of its medicines to treat cancer," the company said at the time.